Growth hormone, insulin-like growth factor-I and somatostatin in human fetus, newborn, mother plasma and amniotic fluid.

Gianni Bona(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Federico Mussa, C Aquili, Paolo Ravanini, Gallina Mr, Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Cigolotti Ac, P Paniccia
PubMed
March 1, 1994
Cited by 16

Related Papers

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Prospective study of multiple sclerosis with early onset
|Multiple Sclerosis Journal|2002|152
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
|Neurology|2018|123